177 related articles for article (PubMed ID: 36327132)
21. Ligand-Modified Erythrocyte Membrane-Cloaked Metal-Organic Framework Nanoparticles for Targeted Antitumor Therapy.
Lin Y; Zhong Y; Chen Y; Li L; Chen G; Zhang J; Li P; Zhou C; Sun Y; Ma Y; Xie Z; Liao Q
Mol Pharm; 2020 Sep; 17(9):3328-3341. PubMed ID: 32804508
[TBL] [Abstract][Full Text] [Related]
22. Piceatannol Prevents Colon Cancer Progression via Dual-Targeting to M2-Polarized Tumor-Associated Macrophages and the TGF-β1 Positive Feedback Signaling Pathway.
Chiou YS; Lan YM; Lee PS; Lin Q; Nagabhushanam K; Ho CT; Pan MH
Mol Nutr Food Res; 2022 Aug; 66(15):e2200248. PubMed ID: 35616191
[TBL] [Abstract][Full Text] [Related]
23. Enhanced antitumor efficacy and reduced systemic toxicity of sulfatide-containing nanoliposomal doxorubicin in a xenograft model of colorectal cancer.
Lin J; Yu Y; Shigdar S; Fang DZ; Du JR; Wei MQ; Danks A; Liu K; Duan W
PLoS One; 2012; 7(11):e49277. PubMed ID: 23145140
[TBL] [Abstract][Full Text] [Related]
24. Tumor associated macrophages and angiogenesis dual-recognizable nanoparticles for enhanced cancer chemotherapy.
Cao D; Liang L; Xu Y; Sun J; Lei M; Wang M; Wei Y; Sun Z
Nanomedicine; 2018 Apr; 14(3):651-659. PubMed ID: 29331387
[TBL] [Abstract][Full Text] [Related]
25. Mannose-methyl-β-cyclodextrin suppresses tumor growth by targeting both colon cancer cells and tumor-associated macrophages.
Ohno Y; Toshino M; Mohammed AFA; Fujiwara Y; Komohara Y; Onodera R; Higashi T; Motoyama K
Carbohydr Polym; 2023 Apr; 305():120551. PubMed ID: 36737200
[TBL] [Abstract][Full Text] [Related]
26. Tumor Microenvironment-Triggered Charge Reversal Polymetformin-Based Nanosystem Co-Delivered Doxorubicin and IL-12 Cytokine Gene for Chemo-Gene Combination Therapy on Metastatic Breast Cancer.
Sun Y; Liu L; Zhou L; Yu S; Lan Y; Liang Q; Liu J; Cao A; Liu Y
ACS Appl Mater Interfaces; 2020 Oct; 12(41):45873-45890. PubMed ID: 32924511
[TBL] [Abstract][Full Text] [Related]
27. The prednisolone phosphate‑induced suppression of the angiogenic function of tumor‑associated macrophages enhances the antitumor effects of doxorubicin on B16.F10 murine melanoma cells in vitro.
Licarete E; Rauca VF; Luput L; Patras L; Sesarman A; Banciu M
Oncol Rep; 2019 Dec; 42(6):2694-2705. PubMed ID: 31578578
[TBL] [Abstract][Full Text] [Related]
28. Protein-Crowned Micelles for Targeted and Synergistic Tumor-Associated Macrophage Reprogramming to Enhance Cancer Treatment.
Sun JH; Liang X; Cai M; Yan L; Chen Z; Guo L; Jing L; Wang Y; Zhou D
Nano Lett; 2022 Jun; 22(11):4410-4420. PubMed ID: 35575719
[TBL] [Abstract][Full Text] [Related]
29. Preparation of folic acid-conjugated, doxorubicin-loaded, magnetic bovine serum albumin nanospheres and their antitumor effects in vitro and in vivo.
Yang R; An Y; Miao F; Li M; Liu P; Tang Q
Int J Nanomedicine; 2014; 9():4231-43. PubMed ID: 25228802
[TBL] [Abstract][Full Text] [Related]
30. Cathepsin S-mediated autophagic flux in tumor-associated macrophages accelerate tumor development by promoting M2 polarization.
Yang M; Liu J; Shao J; Qin Y; Ji Q; Zhang X; Du J
Mol Cancer; 2014 Mar; 13():43. PubMed ID: 24580730
[TBL] [Abstract][Full Text] [Related]
31. A coordinative modular assembly-constructed self-reinforced nano-therapeutic agent for effective antitumor-immune activation.
Zheng Y; Bu F; Xu C; Wu T; Zhou J; Shen W; Yin T
J Control Release; 2024 Jul; 371():588-602. PubMed ID: 38866245
[TBL] [Abstract][Full Text] [Related]
32. Serum Stability and Affinity Optimization of an M2 Macrophage-Targeting Peptide (M2pep).
Ngambenjawong C; Gustafson HH; Pineda JM; Kacherovsky NA; Cieslewicz M; Pun SH
Theranostics; 2016; 6(9):1403-14. PubMed ID: 27375788
[TBL] [Abstract][Full Text] [Related]
33. Marsdenia tenacissima extract disturbs the interaction between tumor-associated macrophages and non-small cell lung cancer cells by targeting HDGF.
Fu JL; Hao HF; Wang S; Jiao YN; Li PP; Han SY
J Ethnopharmacol; 2022 Nov; 298():115607. PubMed ID: 35973634
[TBL] [Abstract][Full Text] [Related]
34. PEG-Sheddable Nanodrug Remodels Tumor Microenvironment to Promote Effector T Cell Infiltration and Revise Their Exhaustion for Breast Cancer Immunotherapy.
Huang T; Zhang Q; Yi J; Wang R; Zhang Z; Luo P; Zeng R; Wang Y; Tu M
Small; 2023 Sep; 19(38):e2301749. PubMed ID: 37211704
[TBL] [Abstract][Full Text] [Related]
35. Hierarchically targetable polysaccharide-coated solid lipid nanoparticles as an oral chemo/thermotherapy delivery system for local treatment of colon cancer.
Shen MY; Liu TI; Yu TW; Kv R; Chiang WH; Tsai YC; Chen HH; Lin SC; Chiu HC
Biomaterials; 2019 Mar; 197():86-100. PubMed ID: 30641267
[TBL] [Abstract][Full Text] [Related]
36. A small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapy.
Mou Q; Ma Y; Zhu X; Yan D
J Control Release; 2016 May; 230():34-44. PubMed ID: 27040815
[TBL] [Abstract][Full Text] [Related]
37. Lactosylated IR820/DOX Co-Assembled Nanodrug for Synergetic Antitumour Therapy.
Jiang Y; Huang C; Luan Y
Int J Nanomedicine; 2020; 15():4431-4440. PubMed ID: 32606687
[TBL] [Abstract][Full Text] [Related]
38. Bioconjugated Manganese Dioxide Nanoparticles Enhance Chemotherapy Response by Priming Tumor-Associated Macrophages toward M1-like Phenotype and Attenuating Tumor Hypoxia.
Song M; Liu T; Shi C; Zhang X; Chen X
ACS Nano; 2016 Jan; 10(1):633-647. PubMed ID: 26650065
[TBL] [Abstract][Full Text] [Related]
39. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.
Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J
Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421
[TBL] [Abstract][Full Text] [Related]
40. Antitumor therapy for breast cancer: Focus on tumor-associated macrophages and nanosized drug delivery systems.
Zhan C; Jin Y; Xu X; Shao J; Jin C
Cancer Med; 2023 May; 12(10):11049-11072. PubMed ID: 36794651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
